Author:
Campbell Erin J.,Lawrence Andrew J.,Perry Christina J.
Funder
National Health and Medical Research Council
Victoria State Government Operational Infrastructure Scheme
Publisher
Springer Science and Business Media LLC
Reference175 articles.
1. Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2000) Ability of baclofen in reducing alcohol craving and intake: II—preliminary clinical evidence. Alcohol Clin Exp Res 24(1):67–71
2. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002a) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37(5):504–508
3. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Colombo G, Gessa GL, Gasbarrini G (2002b) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112(3):226–229
4. Addolorato G, Antonelli M, Cocciolillo F, Vassallo GA, Tarli C, Sestito L, Mirijello A, Ferrulli A, Pizzuto DA, Camardese G, Miceli A, Diana M, Giordaon A, Gasbarrini A, Di Giuda D (2017) Deep transcranial magnetic stimulation of the dorsolateral prefrontal cortex in alcohol use disorder patients: effects on dopamine transporter availability and alcohol intake. Eur Neuropsychopharmacol 27(5):450–461.
https://doi.org/10.1016/j.euroneuro.2017.03.008
5. Agabio R, Colombo G (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 8:140.
https://doi.org/10.3389/fnins.2014.00140
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献